Krishna Institute of Medical Sciences Limited (NSE:KIMS)
535.45
-6.55 (-1.21%)
Feb 21, 2025, 3:29 PM IST
NSE:KIMS Revenue
Krishna Institute of Medical Sciences had revenue of 7.72B INR in the quarter ending December 31, 2024, with 27.49% growth. This brings the company's revenue in the last twelve months to 28.72B, up 17.69% year-over-year. In the fiscal year ending March 31, 2024, Krishna Institute of Medical Sciences had annual revenue of 24.98B with 13.67% growth.
Revenue (ttm)
28.72B
Revenue Growth
+17.69%
P/S Ratio
7.45
Revenue / Employee
5.73M
Employees
5,013
Market Cap
214.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 24.98B | 3.00B | 13.67% |
Mar 31, 2023 | 21.98B | 5.47B | 33.13% |
Mar 31, 2022 | 16.51B | 3.21B | 24.13% |
Mar 31, 2021 | 13.30B | 2.07B | 18.46% |
Mar 31, 2020 | 11.23B | 2.02B | 21.98% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |